Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodelling

Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies

(2014) Arne Astrup   AMERICAN JOURNAL OF CLINICAL NUTRITION

Long-Chain Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid and Blood Pressure: A Meta-Analysis of Randomized Controlled Trials

(2014) P. E. Miller et al.   AMERICAN JOURNAL OF HYPERTENSION

I Prostanoid Receptor-Mediated Inflammatory Pathway Promotes Hepatic Gluconeogenesis Through Activation of PKA and Inhibition of AKT

(2014) S. Yan et al.   DIABETES

Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation

(2014) Christopher D. Buckley et al.   IMMUNITY

Clinical consequences of aspirin and clopidogrel resistance: an overview

(2013) M. D. Mijajlovic et al.   ACTA NEUROLOGICA SCANDINAVICA

Clinical pharmacology of n-3 polyunsaturated fatty acids: non-lipidic metabolic and hemodynamic effects in human patients

(2013) Franca Marangoni et al.   ATHEROSCLEROSIS SUPPLEMENTS

The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Concise Guide to PHARMACOLOGY 2013/14: Enzymes

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cyclooxygenase-2–Derived Prostaglandin E 2 Promotes Injury-Induced Vascular Neointimal Hyperplasia Through the E-prostanoid 3 Receptor

(2013) Jian Zhang et al.   CIRCULATION RESEARCH

D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury

(2013) Takuya Miyahara et al.   FASEB JOURNAL

Dietary fish oil reduces the acute inflammatory response and enhances resolution of antigen-induced peritonitis

(2013) Valgerdur Tomasdottir et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

(2013) Adam J. Pawson et al.   NUCLEIC ACIDS RESEARCH

Mechanisms of aspirin resistance

(2013) Christopher N. Floyd et al.   PHARMACOLOGY & THERAPEUTICS

Omega-3 Fatty Acids and Cardiovascular Disease: New Developments and Applications

(2013) William S. Harris et al.   POSTGRADUATE MEDICINE

The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus

(2013) Amir Abdolahi et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Antiplatelet Treatment for Prevention of Cerebrovascular Events in Patients With Vascular Diseases

(2013) Ghazaleh Gouya et al.   STROKE

Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease

(2012) Jean-Guillaume Dillinger et al.   AMERICAN HEART JOURNAL

Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation

(2012) Mark K. Larson et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice

(2012) Tae-Ho Kim et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Erythrocyte n-3 Fatty Acids and Metabolic Syndrome in Middle-Aged and Older Chinese

(2012) Geng Zhang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation

(2012) D. El Kebir et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The combination of EPA+DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans

(2012) Robert C. Block et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease

(2011) Davide Capodanno et al.   Circulation-Cardiovascular Interventions

Relationship between Coronary Artery Disease and Non-HDL-C, and Effect of Highly Purified EPA on the Risk of Coronary Artery Disease in Hypercholesterolemic Patients Treated with Statins: Sub-Analysis of the Japan EPA Lipid Intervention Study (JELIS)

(2011) Jun Sasaki et al.   Journal of Atherosclerosis and Thrombosis

NK Cells Are Effectors for Resolvin E1 in the Timely Resolution of Allergic Airway Inflammation

(2011) O. Haworth et al.   JOURNAL OF IMMUNOLOGY

Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease: reply to a rebuttal

(2011) E. L. GROVE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Towards a standardization of the murine ferric chloride-induced carotid arterial thrombosis model

(2011) A. P. OWENS III et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Aspirin-Triggered Lipoxin and Resolvin E1 Modulate Vascular Smooth Muscle Phenotype and Correlate with Peripheral Atherosclerosis

(2010) Karen J. Ho et al.   AMERICAN JOURNAL OF PATHOLOGY

Resolvin E1 Regulates Adenosine Diphosphate Activation of Human Platelets

(2010) Gabrielle Fredman et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects

(2010) Da Young Oh et al.   CELL

Novel Lipid Mediators Promote Resolution of Acute Inflammation

(2010) Matthew Spite et al.   CIRCULATION RESEARCH

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation

(2010) M. Pignone et al.   DIABETES CARE

Treatment of Aspirin-Resistant Patients With Omega-3 Fatty Acids Versus Aspirin Dose Escalation

(2010) Eli I. Lev et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Polyunsaturated Omega-3 Fatty Acids on Responsiveness to Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention

(2010) Grzegorz Gajos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease

(2009) Baukje de Roos et al.   BRITISH JOURNAL OF PHARMACOLOGY

Molecular Basis of Restenosis and Novel Issues of Drug-Eluting Stents

(2009) Teruo Inoue et al.   CIRCULATION JOURNAL

Aspirin following PCI: too much of a good thing?

(2009) S. R. Steinhubl et al.   EUROPEAN HEART JOURNAL

Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans

(2009) T. Morris et al.   JOURNAL OF IMMUNOLOGY

Total synthesis of resolvin E1

(2009) Narihito Ogawa et al.   TETRAHEDRON LETTERS

Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives

(2008) William S. Harris et al.   ATHEROSCLEROSIS

Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets

(2008) M. Dona et al.   BLOOD